– PowerLook Tomo Detection – had received approval from the U.S. Food and Drug Administration
(FDA). For those not familiar, PowerLook Tomo Detection is a first-of-its-kind, concurrent-read computer aided detection solution designed to assist radiologists in reading DBT studies. As part of the development for the product, PowerLook Tomo went through a reader study where it showed time savings of 29.2% for a radiologist when reading large data sets without impacting radiologist clinical performance.
Flash forward a year later and our solution has not only been adopted by healthcare organizations worldwide, but has also just been named a finalist for the 2018 Medical Design Excellence Awards (MDEA), the premier awards program for the medtech industry! The MDEA recognizes the technological achievements of medical device manufacturers that work toward improving the quality of
healthcare delivery and accessibility.
Out of hundreds of submissions, we are honored to be named a finalist. In June, our team will be traveling to New York City where the winners will be announced on stage at the MDEA ceremony. The winners are chosen by an impartial panel of judges comprised of clinicians, engineers and designers with
years of experience in the industry. Judgement is based on five criteria, including design and engineering innovations, functional innovations, benefits to overall healthcare, benefits to patients and competitive landscape.
We are honored to have been named a finalist and look forward to networking with our peers at the ceremony in June. Stay tuned for future updates on the results of the MDEA awards and other exciting news to come!